Systematic review of COVID-19 associated with aspergillosis: perspectives for a new diagnosis

Authors

DOI:

https://doi.org/10.33448/rsd-v11i12.34455

Keywords:

Dysfunction pulmonary; Diagnosis; Respiratory syndrome of acute discomfort (ARDS); Fungus culture; Co-infection.

Abstract

The association of severe acute respiratory syndrome 2 (SARS-COV-2) with invasive pulmonary aspergillosis (API) is called CAPA.  Clinical treatment protocols are not described in the world or national literature   resulting in low efficacy and high mortality. The objective was to associate the manifestations of SARS-COV-2 and API, in relation to the diagnostic methods, pulmonary dysfunction   and clinical outcome. The systematic literature review was based on Pubmed, with English descriptors: “aspergilosis”, “covid”, “histology”, boolean "and", with filters: human and published from 2019. 31 articles were identified and 10 were included. The diagnosis for API included research of the Aspergillus galactomannan antigen in serum or sputum, Aspergillus PCR in tracheal aspirate and culture of respiratory samples. The highlighted respiratory compromises are ground-glass opacities, nodular consolidations, bilateral interstitial pulmonary infiltrate, with death as one of the common outcome. CAPA is a co-infection process, future clinical trials are necessary to develop integrated diagnosis, to improve the clinical outcome and minimize mortality.

References

Bienvenu., et al. (2020). No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment. Critical Care. 24:588 https://doi.org/10.1186/s13054-020-03307-5.

Blaize, M., et al (2020). Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient. Emerging Infectious Diseases. 26(7).

Fekkar, A., et al (2020). Fungal infection during COVID-19: Does aspergillus mean secondary invasive aspergillosis?American Journal of Respiratory and Critical Care Medicine. 33(6).

Flikweert, A. W., et al (2020). Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series. Journal of Critical Care. 59 (87).

Gangneux, J. P., et al (2020). Invasive fungal diseases during COVID-19: We should be prepared. Journal de Mycologie Medicale. 23(3), 134-137.

Koehler, P., et al (2020). COVID-19 associated pulmonary aspergillosis. Mycoses, 63(6), 159-162.

Lahmer, T., et al (2020). Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia. Clinical Microbiology and Infection, 2020.

Mitaka, H., et al (2020). Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City. Mycoses, 63(12), 2020.

Nasir, N., et al (2020). COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan. Mycoses, 63(8), 2020.

Neufeld, P. M. (2020). A COVID-19 e o diagnóstico da aspergilose pulmonar invasiva. Revista Brasileira de Análises Clínicas, 52(2), 2020.

Patti, R. K., et al (2020). Subacute Aspergillosis “Fungal Balls” Complicating COVID-19. Journal of Investigative Medicine High Impact Case Reports, v. 8, 2020.

Pemán, J., et al (2020). Fungal co-infection in COVID-19 patients: Should we be concerned? Revista Iberoamericana de Micologia, 2020.

Santana, M. F., et al (2020). Confirmed invasive pulmonary aspergillosis and COVID-19: The value of postmortem findings to support antemortem management. Revista da Sociedade Brasileira de Medicina Tropical, v. 53, 2020.

Schein, F., et al (2020). Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report. Journal de Mycologie Medicale, 30(4), 2020.

Segrelles-Calvo, G., De Saraújo, G. R., & Frases, S (2020). Systemic mycoses: A potential alert for complications in COVID-19 patients. Future MicrobiologyFuture Medicine Ltd., , 1 set. 2020.

Song, G., Liang, G., & Liu, W (2020). Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia, 2020.

Tozzi, P., et al. (2020). COVID-19 Pandemics: A surprising link to bread flour with collateral damage to a prosthetic heart valve. Circulation: Cardiovascular Imaging, 2020.

Van Arkel, A. L. E., et al. (2020). COVID-19-associated pulmonary aspergillosis. American Journal of Respiratory and Critical Care Medicine American Thoracic Society, 1 jul. 2020.

Wang, J., et al (2020). Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: A retrospective case series. Critical Care, 24(1), 2020.

Wu, S., et al (2020). Dynamic Immune Response Profiles and Recovery of a COVID-19 Patient with Coinfection of Aspergillus fumigatus and Other Baseline Diseases: A Case Report. OMICSA Journal of Integrative Biology, 2020.

Published

11/09/2022

How to Cite

GERVÁSIO, . F. M. .; FRANCO, J. V. V.; SAMPAIO, A. de S. .; PASSOS, A. R. dos .; SAKAMOTO, A. M. .; SILVA, D. de S. .; BRAZ, D. C. .; SEIXAS , . G. C. .; SPINDOLA, L. A. .; ABREU , T. M. de . Systematic review of COVID-19 associated with aspergillosis: perspectives for a new diagnosis. Research, Society and Development, [S. l.], v. 11, n. 12, p. e204111234455, 2022. DOI: 10.33448/rsd-v11i12.34455. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/34455. Acesso em: 20 apr. 2024.

Issue

Section

Review Article